US20180000427A1 - Respiratory apparatus with improved flow-flattening detection - Google Patents

Respiratory apparatus with improved flow-flattening detection Download PDF

Info

Publication number
US20180000427A1
US20180000427A1 US15702875 US201715702875A US2018000427A1 US 20180000427 A1 US20180000427 A1 US 20180000427A1 US 15702875 US15702875 US 15702875 US 201715702875 A US201715702875 A US 201715702875A US 2018000427 A1 US2018000427 A1 US 2018000427A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
data samples
obstruction
flow
inspiration
apparatus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US15702875
Inventor
Peter John Deacon Wickham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ResMed Ltd
Original Assignee
ResMed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7278Artificial waveform generation or derivation, e.g. synthesising signals from measured signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/085Measuring impedance of respiratory organs or lung elasticity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/087Measuring breath flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4806Sleep evaluation
    • A61B5/4818Sleep apnoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7282Event detection, e.g. detecting unique waveforms indicative of a medical condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057Pumps therefor
    • A61M16/0066Blowers or centrifugal pumps
    • A61M16/0069Blowers or centrifugal pumps the speed thereof being controlled by respiratory parameters, e.g. by inhalation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057Pumps therefor
    • A61M16/0066Blowers or centrifugal pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06Respiratory or anaesthetic masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A61M2016/0039Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the inspiratory circuit

Abstract

In a respiratory apparatus for treatment of sleep apnea and other disorders associated with an obstruction of a patient's airway and which uses an airflow signal, an obstruction index is generated which detects the flattening of the inspiratory portion of the airflow. The obstruction index is used to differentiate normal and obstructed breathing. The obstruction index is based upon different weighting factors applied to sections of the airflow signal thereby improving sensitivity to various types of respiration obstructions.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a divisional of U.S. application Ser. No. 14/211,443, filed Mar. 14, 2014, which is a continuation of U.S. application Ser. No. 13/586,134, filed Aug. 15, 2012 (now U.S. Pat. No. 8,707,953), which is a continuation of U.S. application Ser. No. 11/611,315, filed on Dec. 15, 2006 (now U.S. Pat. No. 8,739,789), which is a continuation of U.S. application No. 11/325,169, filed Jan. 4, 2006 (now U.S. Pat. No. 7,159,588), which is a continuation of U.S. application Ser. No. 10/950,926, filed Sep. 27, 2004 (now U.S. Pat. No. 7,013,893), which is a continuation of U.S. application Ser. No. 09/924,325, filed Aug. 8, 2001 (now U.S. Pat. No. 6,814,073) which claims priority filing date from U.S. Provisional Application No. 60/228,630, filed Aug. 29, 2000, all of which are hereby incorporated herein by reference.
  • FIELD OF THE INVENTION
  • This invention relates to a method and apparatus for detecting obstruction of the airway of a patient. More specifically, the invention involves an improved method and apparatus for detecting obstruction, either partial or complete, based upon a flattened measure of an inspiratory portion of respiratory airflow. The method is useful in patient ventilators such as those used in the diagnosis and treatment of respiratory conditions including sleep apnea or hypopnea.
  • BACKGROUND OF THE INVENTION
  • The dangers of obstructed breathing during sleep are well known in relation to the Obstructive Sleep Apnea (OSA) syndrome. Apnea, hypopnea and heavy snoring are recognized as causes of sleep disruption and risk factors in certain types of heart disease.
  • The monitoring of upper airway pressure-flow relationships in obstructive sleep apnea has been described in Smith et al., 1988, J. Appl. Physiol. 64:789-795. FIG. 1 of that article shows polygraphic sleep recordings at varying levels of increasing nasal pressure. It was noted that inspiratory volumetric flow plateaued in certain breaths suggesting the presence of airflow limitation. Pressure-flow curves were constructed by plotting midinspiratory airflow against either mask pressure or endoesophageal pressure. The pressure-flow plots of nasal pressure against mean midinspiratory flow were then fit by least-squares linear regression to calculate resistance upstream to the collapsible site.
  • The effect of positive nasal pressure on upper airway pressure-flow relationships has been described in Schwartz et al., 1989, J. Appl Physiol. 66:1626-1634. FIG. 4 of the article shows that pressure-flow tracings plateau at a low pressure level. It was further shown when the pressure was increased, flow did not plateau.
  • The common method of treatment of these syndromes is to administer Continuous Positive Airway Pressure (CPAP). The procedure for administering CPAP treatment has been documented in both the technical and patent literature. Briefly stated, CPAP treatment acts as a pneumatic splint of the airway by the provision of a positive pressure, usually in the range 4-20 cm H2O. The air is supplied by a motor driven blower whose output passes via an air delivery device to sealingly engage a patient's airway. A mask, tracheotomy tube, endotracheal tube, nasal pillows or other appropriate device may be used. An exhaust port is provided in a delivery tube proximate to the air delivery device. Other forms of CPAP, such as bi-level CPAP, and self-titrating CPAP, are described in U.S. Pat. Nos. 5,148,802 and 5,245,995 respectively.
  • With regard to the control of CPAP treatment, various techniques are known for sensing and detecting abnormal breathing patterns indicative of obstruction. For example, U.S. Pat. No. 5,245,995 describes how snoring and abnormal breathing patterns can be detected by inspiration and expiration pressure measurements while sleeping, thereby leading to early indication of preobstructive episodes or other forms of breathing disorder. Particularly, patterns of respiratory parameters are monitored, and CPAP pressure is raised on the detection of pre-defined patterns to provide increased airway pressure to ideally prevent the occurrence of the obstructive episodes and the other forms of breathing disorder.
  • Similarly, U.S. Pat. No. 5,335,654 (Rapoport) lists several indices said to be indications of flow limitation and/or partial obstruction patterns including: (1) The derivative of the flow signal equals zero; (2) The second derivative between peaks of the flow signal is zero for a prolonged interval; (3) The ratio of early inspirational flow to midinspirational flow is less than or equal to 1. The patent further lists events said to be indications of obstructions: (1) Reduced slope of the line connecting the peak inspiratory flow to the peak expiratory flow; (2) Steep upward or downward stroke (dV/dt) of the flow signal; and (3) Ratio of inspiratory flow to expiratory flow over 0.5.
  • U.S. Pat. No. 5,645,053 (Remmers) describes calculating a flatness index, wherein flatness is defined to be the relative deviation of the observed airflow from the mean airflow. In Remmers, individual values of airflow are obtained between 40% and 80% of the inspiratory period. The mean value is calculated and subtracted from individual values of inspiratory flow. The individual differences are squared and divided by the total number of observations minus one. The square root of this result is used to determine a relative variation. The relative variation is divided by the mean inspiratory airflow to give a relative deviation or a coefficient of variation for that breath.
  • In commonly owned U.S. Pat. No. 5,704,345, Berthon-Jones also discloses a method for detecting partial obstruction of a patient's airway. Generally, the method involves a determination of two alternative obstruction index values based upon the patient's monitored respiratory airflow. Either obstruction index may then be compared to a threshold value. Essentially, the index values may be characterized as shape factors that detect a flattening of an inspiratory portion of a patient's respiratory airflow. The first shape factor involves a ratio of the mean of a midportion of the inspiratory airflow of the breathing cycle and the mean of the inspiratory airflow. The formula for shape factor 1 is as follows:
  • shapefactor_ 1 = 1 33 t = 16 48 f s ( t ) M
  • where fs(t) is a sample of the patient's inspiratory airflow and M is the mean of inspiratory airflow given by the following:
  • M = 1 65 t = 1 65 f s ( t )
  • A second shape factor involves a ratio of the Root Mean Square deviation of a midportion of inspiratory airflow and the mean inspiratory airflow according to the formula:
  • shapefactor_ 2 = 1 33 t = 16 48 ( f s ( t ) - M ) 2 M
  • Berthon-Jones further discloses a scaling procedure applied to the inspiratory airflow samples such that the mean M of the samples fs(t) is unity (M=1). This scaling procedure simplifies both shape factor formulas. Additional adjustments to fs(t) including averaging and the elimination of samples from erratic breaths such as coughs, sighs, hiccups, etc., are also taught by Berthon-Jones. The foregoing U.S. patent is hereby incorporated by reference.
  • The present invention involves an improved method and apparatus for detecting some forms of obstruction based upon the flattening of the inspiratory airflow.
  • BRIEF SUMMARY OF THE INVENTION
  • An objective of the present invention is to provide an apparatus in which obstruction, either partial or complete, of the patient's airway is detected by analyzing respiratory airflow.
  • A further objective is to provide an apparatus in which a novel algorithm for detecting airway obstruction is implemented without using additional components or making substantial changes to the structure of existing respiratory apparatus.
  • Accordingly, a respiratory apparatus is provided in which the respiratory airflow of a patient is continuously monitored. The part of respiratory airflow associated with inspiration is identified and sampled. From these inspiration samples, several samples representing a midportion of inspiration are identified. One or more weighting parameters or weighting factors are associated with each midportion sample. These weights and midportion samples are then used to calculate an obstruction index. Finally, this obstruction index is compared to a threshold value which comparison is used to adjust or control ventilatory assistance.
  • In one embodiment, weighting factors are applied based on whether the inspiratory airflow samples are less than or greater than a threshold level, such as the mean airflow.
  • In another embodiment, different weighting factors are applied to samples based on their time positions in a breath. Samples taken prior to a certain event during inspiration, for example, samples preceding the half way point of inspiration, are assigned lower weighting factors than samples succeeding the event. An obstruction index is then calculated using these samples with their corresponding weighting factors.
  • In one aspect, the subject invention pertains to a respiratory apparatus which includes a gas source adapted to selectively provide pressurized breathable gas to a patient, a flow sensor to sense the respiratory airflow from the patient and to generate an airflow signal indicative of airflow, an obstruction detector coupled to said flow sensor which includes a weight assigning member arranged to assign several weight factors to portions of the flow signal and to generate an obstruction signal using the weighted portions, and a controller coupled to the flow sensor and arranged to control the operation of the gas source, receive the obstruction signal and alter the operation of the gas source in response to the obstruction signal.
  • Another aspect of the invention concerns an apparatus for monitoring and/or treating a patient having a sleep disorder, the apparatus including a flow sensor that senses patient respiration and generates a corresponding flow signal; and an obstruction detector coupled to the flow sensor and adapted to determine a weighted average signal, the weighted average signal being dependent on a weighted average of the flow signal in accordance with one of an amplitude and a time position of portions of the flow signal, the obstruction detector including a signal generator that generates a signal indicative of an airway obstruction based on the weighted average signal.
  • A further aspect of the invention concerns an apparatus for treating a patient having a sleep disorder, the apparatus comprising a mask, a gas source selectively supplying pressurized breathable air to the patient through the mask, a flow sensor that senses airflow and generates a flow signal indicative of respiration, an obstruction detector coupled to the flow sensor and adapted to determine a weighted average signal, the weighted average signal being dependent on a weighted average of the flow signal in accordance with one of an amplitude and a time position of portions of the flow signal, and a controller receiving the obstruction signal and generating in response a command for activating the gas source.
  • Another aspect of the invention concerns a method for detecting obstruction in the airways of a patient, including measuring an air flow of the patient, detecting a predetermined section of said air flow, assigning weights to portions of said predetermined section and determining an index value for said predetermined section based on said weights as a measure of the obstruction.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows a block diagram of a respiratory apparatus constructed in accordance with this invention.
  • FIG. 2 shows a flow chart illustrating the operation of the apparatus of FIG. 1.
  • FIG. 3 shows the inspiration phases of typical respiration signals for a healthy person and a person with a partial airway obstruction.
  • FIG. 4 shows a portion of a normal respiration signal from a patient.
  • FIGS. 5 and 6 show portions of two different respiration signals characteristic from patients with sleep apnea.
  • FIG. 7 shows a flow chart for determining the flattening indices for the respiration signals of FIGS. 4-6.
  • FIG. 8 shows a normal breathing pattern for a person without respiratory obstructions to illustrate the determination of two improved obstruction indices.
  • FIGS. 9, 10, and 11 show various breathing patterns with obstructions identifiable using the improved indices.
  • FIG. 12 shows an example of how a flow curve can be checked to insure that it is a valid respiration curve.
  • FIG. 13 shows an example of how a typical respiration flow curve can be trimmed.
  • DETAILED DESCRIPTION Apparatus and Methodology
  • FIG. 1 shows an example respiratory apparatus 10 constructed in accordance with the invention. The respiratory apparatus 10 includes a mask 12 connected to a blower 14 by a flexible tube 16. The mask 12 is fitted to the patient and may be either a nose mask or a face mask. The blower 14 with an air outlet 22 is driven by a motor 18 in accordance with control signals from a servocontroller 20. This arrangement allows the respiratory apparatus 10 to deliver pressurized air (or air enriched with oxygen from a source, not shown). The pressurized air is delivered by tube 16 to the mask 12. The tube 16 is provided with a narrow exhaust port 26 through which air exhaled by the patient is expelled.
  • A control circuit 24 is used to control the operation of servocontroller 20 and motor 18 using certain predetermined criteria, thereby defining modes of operation for the apparatus 10. Preferably, in accordance with this invention, the control circuit 24 is adapted to operate the apparatus 10 to provide CPAP to the patient.
  • Control circuit 24 includes a flow restrictive element 28. Tubes 30 and 31 lead from restrictive element 28 to a differential pressure transducer 34. Tube 30 is also connected through another tube 33 to a mask pressure transducer 32.
  • The mask pressure transducer 32 generates a first electrical signal which is amplified by an amplifier 36 to generate an output P(t) proportional to the air pressure within the mask 12. This output is fed directly to the servocontroller 20.
  • The differential pressure transducer 34 senses the differential pressure across the flow restrictive element 28, which differential pressure is related to the air flow rate through the flow restrictive element 28 and tube 16. Differential pressure transducer 34 generates a second electrical signal that is amplified by an amplifier 38. This amplified signal F(t) is termed an air flow signal since it represents the air flow through the tube 16.
  • The air flow signal F(t) is fed to a filter 40 which filters the signal within a preset range. The outputs of the filter 40 and amplifier 36 are fed to an ADC (analog-to-digital) converter 42, which generates corresponding signals fi to a microprocessor 44. The microprocessor 44 generates analog control signals that are converted into corresponding digital control signals by DAC 46 and used as a reference signal Pset (t) for the servo 20.
  • One method for the operation of a respiratory apparatus 10 is shown in the flow chart of FIG. 2. Individuals skilled in the art will recognize other methodologies for utilizing the improved flow flattening index that is disclosed herein. The embodiment of the methodology of FIG. 2 is also detailed in U.S. Pat. No. 5,704,345 (the '345 patent). The first step 100 is the measurement of respiratory flow (rate) over time. This information is processed in step 102 to generate Index values to be used as qualitative measures for subsequent processing. Thus, Step 102 includes the generation of obstruction index values based upon the weighting method as disclosed herein. Step 104 detects whether an apnea is occurring by comparison of the breathing Index with a threshold value.
  • If the answer in step 104 is “Yes”, an apnea is in progress and there then follows a determination of patency in step 110. If there is patency of the airway, a central apnea with an open airway is occurring, and, if desired, the event is logged in step 112. If the result of step 110 is that the airway is not patent, then a total obstructive apnea or a central apnea with closed airway is occurring, which results in the commencement or increase in CPAP treatment pressure in step 108. If desired, step 108 may include the optional logging of the detected abnormality.
  • If the answer in step 104 is “No”, one or more obstruction indices, such as the improved flow flattening indices, are compared with threshold values in step 106, by which the determination of obstruction of the airway is obtained. If the answer is “Yes” in step 106, then there is a partial obstruction, and if “No”, there is no obstruction (normalcy).
  • Step 108 applies in the case of a complete or partial obstruction of the airway a consequential increase in CPAP treatment pressure. In the instance of normal breathing with no obstruction, the CPAP treatment pressure is reduced, in accordance with usual methodologies that seek to set the minimal pressure required to obviate, or at least reduce, the occurrence of apneas. The amount of reduction in step 107 may, if desired, be zero. Similarly, in the event of a central apnea with patent airway (step 110, 112) treatment pressure is not increased. Such increases in pressure reflexively inhibit breathing, further aggravating the breathing disorder.
  • Improved Flow Flattening Indices
  • FIG. 3 depicts an airflow signal with respect to the inspiratory portion of a typical breathing cycle. During the inspiratory portion of the breathing cycle of a healthy person, the airflow rises smoothly with inspiration, reaches a peak and falls smoothly to zero. However, a patient with a partially obstructed airway exhibits a breathing pattern characterized by a significant flat zone during inspiration. Theoretically, for an obstructed flow, as the degree of partial obstruction increases, the airflow signal for inspiration would tend to a square wave.
  • As previously discussed, the '345 patent describes two shape factors useful in testing for a flattening of the inspiratory portion of a patient's breathing cycle. In the preferred embodiment of the invention, the resulting obstruction index or flow flattening index (FFI) for each shape factor may be compared to unique threshold values. While the approach works well in many instances, it may not detect certain obstruction patterns.
  • This can be illustrated by an examination of FIGS. 4-6. FIGS. 4-6 depict portions of respiration cycles. FIG. 4 shows a normal respiration flow and FIG. 5 shows a severely obstructed respiration cycle in which the inspiration period is characterized by two high positive lobes A and B and a relatively flat zone C between lobes A and B. In FIG. 4, the RMS deviation is indicated by the shaded area under the respiration flow curve and above the mean inspiration flow. In FIG. 5, the RMS deviation is indicated by the shaded area above the respiration flow curve and below the mean inspiration flow. As seen in FIG. 5, due to obstruction, the mean inspiration flow is greater than it would be without the second positive lobe B. Therefore, when analyzing the flow using shape factors of the '345 patent, the highly restricted and abnormal flow of FIG. 5 would not be detected as an obstruction.
  • Similarly, FIG. 6 shows another possible respiration curve for a patient with a partial airway obstruction. This curve includes an abnormally wide initial positive lobe D preceding a flat portion E. Once again, because of the large lobe D the mean inspiration flow is higher than for the more typical flow of FIG. 3. Using the prior art obstruction index, this condition may be detected as normal rather than being properly detected as an obstructed flow.
  • In order to detect these obstructions while continuing to properly respond to non-obstructed flows like the one of FIG. 4, the present invention assigns different weighting factors to the inspiration flow samples depending on:
      • (a) the magnitude of each sample with respect to the mean inspiration flow; and
      • (b) the time-wise position of each sample with respect to a time reference such as mid-inspiration.
  • By assigning a different weighting factor to a sample that is less than a particular value, for example, the mean flow, during the obstruction index or FFI calculation, there is an improved sensitivity to the respiration signal of FIG. 5 without affecting the FFI for normal breathing where most of the flow is greater than the mean.
  • Similarly, by assigning a different weighting factor to samples that occur after a time reference point, the subsequent samples become more significant. This improves sensitivity to the respiration signal of FIG. 6 without affecting the FFI for other breaths that are symmetrical in time about the center point of the inspiration.
  • An algorithm using one form of the invention for calculating the improved FFI is shown in FIG. 7. In step 100 of FIG. 2, a typical flow rate curve F (defined by a plurality of samples fi where i is an index from 1 to the total number of samples n) is obtained. In step 200 of FIG. 7, the curve F is checked to insure that it is a valid inspiration curve. Next, in step 201 the curve F is trimmed to eliminate all samples fi outside of the inspiration period. Methods of implementing steps 200 and 201 are discussed in more detail below. In step 202, a mean M is calculated for all the inspiration samples 1 through n using conventional techniques.
  • In step 204 two weighting factors which may be designated as value dependent factors wi and time dependent factors vi are assigned to each of the samples fi based respectively on the amplitude of each sample and its time position in relation to the inspiration mean M and its center point respectively. For example, the factors wi and vi may be assigned for each flow measurement fi using the following rules:
  • A1. If fi>M then wi=1
  • A2. If fi<M then wi=0.5
  • B 1. If fi is taken prior to the inspiration center point, then vi=0.75.
  • B2. If fi is taken after the inspiration center, then vi=1.25.
  • Next, in step 206 two alternative FFI or obstruction indices are calculated using the formulas:
  • value_weighted _index = i = j k W i · f i - M M · d time_weighted _index = i = j k V i · f i - M M · d
  • Where j is the first and k is the last sample relative to a midportion or center half of the inspiration curve F and d is the number of samples of the midportion of inspiration or center half as shown in FIGS. 3-6, and M is the mean of the inspiration curve F.
  • Alternatively, the algorithm may be described by the following steps:
      • Check the flow samples to confirm they represent a valid inspiration cycle with a shape within acceptable bounds.
      • Trim samples from any “pre-inspiratory period”;
      • Find the mean of the inspiration flow samples;
      • Sum the weighed absolute difference of the flow samples from mean for samples in the center half or mid portion of inspiration:
        • If flow sample is >mean, sum the difference (flow-mean);
        • If flow sample is <mean, sum ½ the difference;
        • If flow sample is before the center point of the inspiration, use 75% of the difference from above;
        • If flow sample is after the center point of the inspiration, use 125% of the difference from above;
      • Scale the sum by the mean and inspiration time to produce the flattening index: FFI=weighed absolute sum/(Center half time*mean inspiration flow).
  • As discussed above, in step 200 of FIG. 7, the curve F is checked to insure that it corresponds to a valid inspiration curve. The flow curve F is checked against an upper and lower bound to prevent processing of an inspiratory curve corrupted by a cough, sigh, etc. For example, as shown in FIG. 12, the curve F may be rejected if it exceeds at any time an upper limit curve UL or falls below a lower limit curve LL. UL may be selected at about 150% of the mean inspiratory flow and LL may be selected at about 50% of the mean inspiratory flow.
  • In step 201 the respiration curve is trimmed to eliminate samples fi occurring before the actual inspiration period. One method of trimming includes the steps:
      • (1) determine the point where the flow reaches 75% of the peak inspiratory flow;
      • (2) determine the point where the flow reaches 25% of the peak inspiratory flow;
      • (3) extrapolate a line through these two points to the zero flow line to determine the point at the beginning of inspiration but use the first sample if the point is to the left of the first sample.
  • This trimming method is illustrated in FIG. 13. With reference to the figure, the respiration curve F crosses the zero flow level at T0. Once the maximum inspiratory flow is reached, two intermediate flow levels are determined: the ¼ inspiratory flow level (i.e., the flow equaling 25% of the maximum inspiratory flow) and the ¾ inspiratory flow level (i.e., the flow equaling 75% of the maximum inspiratory flow). In FIG. 13, curve F crosses these two levels at points F1 and F2, respectively. Using the times T1 and T2, corresponding to the points F1 and F2, the curve F is approximated by a line L. This line is then extended to the zero flow level to determine an extrapolated time TS as the starting time for inspiration period for curve F. Samples fi obtained prior to TS are ignored.
  • The improvement resulting from the use of the above described value and time weighted obstruction indices can be seen with an examination of simulated tests. To this end, FIGS. 8, 9, 10 and 11 show breathing patterns of patients with both normal and obstructed respiration. These patterns were analyzed using the weighted indices of the present invention, as well as the shape factor 2 that uses equal weight samples fi as described in the '345 patent. The results of the tests are shown in the table below.
  • TABLE I
    Equal weight Value weighted Time weighted
    Index index index
    FIG. 8 0.26 0.25 0.25
    FIG. 9 0.24 0.139 0.133
    FIG. 10 0.31 0.18 0.13
    FIG. 11 0.37 0.27 0.23
  • The weighted indices range from 0.3, which indicates no flattening or obstruction, to 0, which indicates gross obstruction. The separation point between these two classifications is 0.15, which may be used as a threshold value for comparison as described below.
  • FIG. 8 shows a normal breathing pattern. As can be seen from the table, all three indices have approximately the same value, thereby indicating that no increase in CPAP is needed.
  • FIG. 9 is similar in form to FIG. 5 in that it shows a pattern with two lobes separated by a relatively flat region. As seen in the table, if the equal weight index is used, no obstruction is found, while both improved indices are below the threshold and, therefore, both indicate an obstructed breathing pattern.
  • FIG. 10 shows a pattern similar to the one in FIG. 6 that starts off with a high initial lobe and then decays relatively slowly. For this pattern, the equal weight index and the value weighted index are both above the threshold. However, the time weighted index is below the threshold indicating an obstructed breathing pattern.
  • Finally, FIG. 11 shows another normal breathing pattern which has a shape somewhat different from the shape shown in FIG. 8. The three indices in the Table are all above the threshold level thereby indicating a normal pattern as well.
  • Although the invention has been described with reference to a particular embodiment, it is to be understood that this embodiment is merely illustrative of the application the principles of the invention. Thus, it is to be understood that numerous modifications may be made in the illustrative embodiment of the invention and other arrangements may be devised without departing from the spirit and scope of the invention. For example, while the preferred embodiment of the invention applies weighted samples to formulae which are used to identify a flattening of airflow, a similar method might be used with other formulae that detect roundness of flow or its deviation there from using a sinusoidal or other similar function.

Claims (18)

  1. 1. A method for determining the presence of a respiratory obstruction with a processor, the method comprising:
    accessing data samples from a signal generated by a sensor configured to detect flow, the data samples representing an inspiratory portion of a respiratory cycle; and
    generating an obstruction signal in an obstruction detector of the processor when the data samples have, as a function of time, an abnormally wide initial positive lobe preceding a relatively flat portion.
  2. 2. The method of claim 1, wherein at least some of the data samples are successive.
  3. 3. The method of claim 1, wherein at least some of the data samples are in regular intervals.
  4. 4. The method of claim 1, wherein magnitudes and positions of the respective positive lobes are assessed against a mean inspiration flow and a mid-inspiration point of the respective inspiration cycle.
  5. 5. A method of a processor for determining the presence of a respiratory obstruction, the method comprising:
    accessing data samples from a signal generated by a sensor configured to detect flow, the data samples representing breath data; and
    generating an obstruction signal in an obstruction detector with the processor when at least one breathing cycle in the data samples has, during an inspiratory portion, an abnormally wide initial positive lobe preceding a relatively flat portion.
  6. 6. The method of claim 5, wherein at least some of the data samples are successive.
  7. 7. The method of claim 5, wherein at least some of the data samples are in regular intervals.
  8. 8. The method of claim 5, wherein magnitudes and positions of the respective positive lobes are assessed against a mean inspiration flow and a mid-inspiration point of the respective inspiration cycle.
  9. 9. A method for determining a response for a respiratory obstruction with a processor, the method comprising:
    accessing data samples from a signal generated by a sensor configured to detect flow, the data samples representing breath data;
    detecting at least one breathing cycle in the data samples that has, during an inspiratory portion, an abnormally wide initial positive lobe preceding a relatively flat portion,
    calculating an obstruction index by assigning different weighting factors to inspiratory flow samples depending on a magnitude of each sample with respect to a mean inspiration flow and a time-wise position of each sample with respect to a mid-inspiration point; and
    determining a command signal for activating or altering an operation of a respiratory apparatus, based on the calculated obstruction index.
  10. 10. An apparatus for determining the presence of a respiratory obstruction comprising:
    a processor configured to:
    access data samples from a signal generated by a sensor configured to detect flow, the data samples representing an inspiratory portion of a respiratory cycle; and
    generate an obstruction signal in an obstruction detector of the processor when the data samples have, as a function of time, an abnormally wide initial positive lobe preceding a relatively flat portion.
  11. 11. The apparatus of claim 10, wherein at least some of the data samples are successive.
  12. 12. The apparatus of claim 10, wherein at least some of the data samples are in regular intervals.
  13. 13. The apparatus of claim 10, wherein magnitudes and positions of the respective positive lobes are assessed against a mean inspiration flow and a mid-inspiration point of the respective inspiration cycle.
  14. 14. An apparatus for determining the presence of a respiratory obstruction, the apparatus comprising:
    a processor configured to:
    access data samples from a signal generated by a sensor configured to detect flow, the data samples representing breath data; and
    generate an obstruction signal in an obstruction detector with the processor when at least one breathing cycle in the data samples has, during an inspiratory portion, an abnormally wide initial positive lobe preceding a relatively flat portion.
  15. 15. The apparatus of claim 14, wherein at least some of the data samples are successive.
  16. 16. The apparatus of claim 14, wherein at least some of the data samples are in regular intervals.
  17. 17. The apparatus of claim 14, wherein magnitudes and positions of the respective positive lobes are assessed against a mean inspiration flow and a mid-inspiration point of the respective inspiration cycle.
  18. 18. An apparatus for determining a response for a respiratory obstruction, the apparatus comprising:
    a processor configured to:
    access data samples from a signal generated by a sensor configured to detect flow, the data samples representing breath data;
    detect at least one breathing cycle in the data samples that has, during an inspiratory portion, an abnormally wide initial positive lobe preceding a relatively flat portion,
    calculate an obstruction index by assigning different weighting factors to inspiratory flow samples depending on a magnitude of each sample with respect to a mean inspiration flow and a time-wise position of each sample with respect to a mid-inspiration point; and
    determine a command signal for activating or altering an operation of a respiratory apparatus, based on the calculated obstruction index.
US15702875 2000-08-29 2017-09-13 Respiratory apparatus with improved flow-flattening detection Pending US20180000427A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US22863000 true 2000-08-29 2000-08-29
US09924325 US6814073B2 (en) 2000-08-29 2001-08-08 Respiratory apparatus with improved flow-flattening detection
US10950926 US7013893B2 (en) 2000-08-29 2004-09-27 Respiratory apparatus with improved flow-flattening detection
US11325169 US7159588B2 (en) 2000-08-29 2006-01-04 Respiratory apparatus with improved flow-flattening detection
US11611315 US8739789B2 (en) 2000-08-29 2006-12-15 Respiratory apparatus with improved flow-flattening detection
US13586134 US8707953B2 (en) 2000-08-29 2012-08-15 Respiratory apparatus with improved flow-flattening detection
US14211443 US9782133B2 (en) 2000-08-29 2014-03-14 Respiratory apparatus with improved flow-flattening detection
US15702875 US20180000427A1 (en) 2000-08-29 2017-09-13 Respiratory apparatus with improved flow-flattening detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15702875 US20180000427A1 (en) 2000-08-29 2017-09-13 Respiratory apparatus with improved flow-flattening detection

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US14211443 Division US9782133B2 (en) 2000-08-29 2014-03-14 Respiratory apparatus with improved flow-flattening detection

Publications (1)

Publication Number Publication Date
US20180000427A1 true true US20180000427A1 (en) 2018-01-04

Family

ID=22857981

Family Applications (7)

Application Number Title Priority Date Filing Date
US09924325 Active 2021-12-26 US6814073B2 (en) 2000-08-29 2001-08-08 Respiratory apparatus with improved flow-flattening detection
US10950926 Active US7013893B2 (en) 2000-08-29 2004-09-27 Respiratory apparatus with improved flow-flattening detection
US11325169 Active US7159588B2 (en) 2000-08-29 2006-01-04 Respiratory apparatus with improved flow-flattening detection
US11611315 Active 2023-04-06 US8739789B2 (en) 2000-08-29 2006-12-15 Respiratory apparatus with improved flow-flattening detection
US13586134 Active US8707953B2 (en) 2000-08-29 2012-08-15 Respiratory apparatus with improved flow-flattening detection
US14211443 Active 2022-11-13 US9782133B2 (en) 2000-08-29 2014-03-14 Respiratory apparatus with improved flow-flattening detection
US15702875 Pending US20180000427A1 (en) 2000-08-29 2017-09-13 Respiratory apparatus with improved flow-flattening detection

Family Applications Before (6)

Application Number Title Priority Date Filing Date
US09924325 Active 2021-12-26 US6814073B2 (en) 2000-08-29 2001-08-08 Respiratory apparatus with improved flow-flattening detection
US10950926 Active US7013893B2 (en) 2000-08-29 2004-09-27 Respiratory apparatus with improved flow-flattening detection
US11325169 Active US7159588B2 (en) 2000-08-29 2006-01-04 Respiratory apparatus with improved flow-flattening detection
US11611315 Active 2023-04-06 US8739789B2 (en) 2000-08-29 2006-12-15 Respiratory apparatus with improved flow-flattening detection
US13586134 Active US8707953B2 (en) 2000-08-29 2012-08-15 Respiratory apparatus with improved flow-flattening detection
US14211443 Active 2022-11-13 US9782133B2 (en) 2000-08-29 2014-03-14 Respiratory apparatus with improved flow-flattening detection

Country Status (4)

Country Link
US (7) US6814073B2 (en)
EP (1) EP1313526A4 (en)
JP (3) JP5099866B2 (en)
WO (1) WO2002018002A1 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7073501B2 (en) * 1999-02-04 2006-07-11 Univerity Technologies International Inc. Ventilatory stabilization technology
US6814073B2 (en) 2000-08-29 2004-11-09 Resmed Limited Respiratory apparatus with improved flow-flattening detection
US7168429B2 (en) 2001-10-12 2007-01-30 Ric Investments, Llc Auto-titration pressure support system and method of using same
US7938114B2 (en) 2001-10-12 2011-05-10 Ric Investments Llc Auto-titration bi-level pressure support system and method of using same
DE10248590B4 (en) * 2002-10-17 2016-10-27 Resmed R&D Germany Gmbh A method and apparatus for performing signal processing of an observation with the respiratory activity of a person in connection measuring signal
CN1767785B (en) * 2003-01-30 2015-08-26 康普麦迪克斯有限公司 Algorithms for automatic titration of positive air pressure
US8381729B2 (en) 2003-06-18 2013-02-26 Breathe Technologies, Inc. Methods and devices for minimally invasive respiratory support
US7588033B2 (en) 2003-06-18 2009-09-15 Breathe Technologies, Inc. Methods, systems and devices for improving ventilation in a lung area
EP1638632A4 (en) * 2003-06-18 2009-05-13 Resmed Ltd Method and apparatus for monitoring bariatric parameters and sleep disordered breathing
CA2536090C (en) 2003-08-18 2014-07-22 Anthony D. Wondka Method and device for non-invasive ventilation with nasal interface
EP1691871A4 (en) * 2003-11-25 2010-09-29 Resmed Ltd Vent system for cpap patient interface used in treatment of sleep disordered breathing
US7988640B2 (en) * 2003-11-26 2011-08-02 Resmed Limited Macro-control of treatment for sleep disordered breathing
US8011365B2 (en) * 2003-12-29 2011-09-06 Resmed Limited Mechanical ventilation in the presence of sleep disordered breathing
EP1737520A4 (en) * 2004-04-15 2009-10-28 Resmed Ltd Snoring treatment apparatus and methods of managing snorers
ES2362300T3 (en) 2005-05-06 2011-07-01 Ginevri S.R.L. Apparatus for nasal ventilation, particularly for assisted ventilation newborn synchronized flow.
US7958892B2 (en) 2005-07-29 2011-06-14 Resmed Limited Air delivery system
US7798144B2 (en) 2005-07-29 2010-09-21 Resmed Limited Life style flow generator and mask system
US9629572B2 (en) 2005-08-26 2017-04-25 Resmed Limited Sleep disorder diagnostic system and method
JP2009508645A (en) 2005-09-20 2009-03-05 グレゴリー カプスト, System for assisting the breathing of the patient, methods, and apparatus
US7422015B2 (en) * 2005-11-22 2008-09-09 The General Electric Company Arrangement and method for detecting spontaneous respiratory effort of a patient
CN105126215A (en) 2006-02-17 2015-12-09 瑞思迈有限公司 Combination enhanced therapy
US8607793B2 (en) * 2006-03-06 2013-12-17 Resmed Limited Method and apparatus for improved flow limitation detection of obstructive sleep apnea
US20070227538A1 (en) * 2006-03-08 2007-10-04 Bernd Scholler Method and device for controlling a ventilator
DE102007006689A1 (en) * 2006-03-31 2007-10-18 Weinmann Geräte für Medizin GmbH & Co. KG Apparatus and method for obstruction detection during apnea by an additional pressure stage
WO2007142812A3 (en) 2006-05-18 2008-10-16 Breathe Technologies Inc Tracheotomy method and device
US20080216831A1 (en) * 2007-03-08 2008-09-11 Mcginnis William J Standalone cpap device and method of using
JP5657380B2 (en) * 2007-05-11 2015-01-21 レスメド・リミテッドResMedLimited Automatic control for the detection of flow limitation
WO2008144589A1 (en) 2007-05-18 2008-11-27 Breathe Technologies, Inc. Methods and devices for sensing respiration and providing ventilation therapy
EP2017586A1 (en) * 2007-07-20 2009-01-21 Map-Medizintechnologie GmbH Monitor for CPAP/Ventilator apparatus
US20090025725A1 (en) * 2007-07-26 2009-01-29 Uti Limited Partnership Transient intervention for modifying the breathing of a patient
US20090078255A1 (en) * 2007-09-21 2009-03-26 Bowman Bruce R Methods for pressure regulation in positive pressure respiratory therapy
US20090078258A1 (en) * 2007-09-21 2009-03-26 Bowman Bruce R Pressure regulation methods for positive pressure respiratory therapy
JP5519510B2 (en) 2007-09-26 2014-06-11 ブリーズ・テクノロジーズ・インコーポレーテッド Ventilation equipment
CN101888868B (en) 2007-09-26 2014-01-22 呼吸科技公司 Methods and devices for treating sleep apnea
EP2274036A4 (en) 2008-04-18 2014-08-13 Breathe Technologies Inc Methods and devices for sensing respiration and controlling ventilator functions
US8776793B2 (en) 2008-04-18 2014-07-15 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US8834387B2 (en) * 2008-06-13 2014-09-16 Sagatech Electronics Inc. Detection of airway resistance
EP2326376A4 (en) 2008-08-22 2014-10-01 Breathe Technologies Inc Methods and devices for providing mechanical ventilation with an open airway interface
US8250903B2 (en) * 2009-03-23 2012-08-28 President And Fellows Of Harvard College Biological particle collector and method for collecting biological particles
US10046133B2 (en) 2009-04-02 2018-08-14 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation for providing ventilation support
US9132250B2 (en) 2009-09-03 2015-09-15 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US9962512B2 (en) 2009-04-02 2018-05-08 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
US9272105B2 (en) * 2010-07-09 2016-03-01 New York University System and method for diagnosis and treatment of obstructive sleep apnea
JP6297329B2 (en) 2010-09-30 2018-03-20 ブリーズ・テクノロジーズ・インコーポレーテッド Nose interface device
CN103501690B (en) * 2011-03-23 2016-10-26 瑞思迈有限公司 Adequate ventilation of detection
US9993605B2 (en) * 2011-06-21 2018-06-12 Resmed Limited PAP system
US9192795B2 (en) 2011-10-07 2015-11-24 Honeywell International Inc. System and method of calibration in a powered air purifying respirator
US9808656B2 (en) 2012-01-09 2017-11-07 Honeywell International Inc. System and method of oxygen deficiency warning in a powered air purifying respirator
US20150059755A1 (en) * 2012-04-13 2015-03-05 Resmed Limited Apparatus and methods for ventilatory treatment
US9724017B2 (en) 2013-07-03 2017-08-08 Breathe Technologies, Inc. Respiratory cycle patient ventilation flow limitation detection
US9839760B2 (en) 2014-04-11 2017-12-12 Vyaire Medical Capital Llc Methods for controlling mechanical lung ventilation
US9956365B2 (en) 2014-04-11 2018-05-01 Vyaire Medical Capital Llc Lung ventilation apparatus
US20150290409A1 (en) * 2014-04-11 2015-10-15 Carefusion 2200, Inc. Methods for controlling mechanical lung ventilation
EP3270994A1 (en) * 2015-03-20 2018-01-24 ResMed Limited Methods and apparatus for ventilatory treatment of respiratory disorders

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777962A (en) * 1986-05-09 1988-10-18 Respitrace Corporation Method and apparatus for distinguishing central obstructive and mixed apneas by external monitoring devices which measure rib cage and abdominal compartmental excursions during respiration
US5522382A (en) * 1987-06-26 1996-06-04 Rescare Limited Device and method for treating obstructed breathing having a delay/ramp feature
US5199424A (en) 1987-06-26 1993-04-06 Sullivan Colin E Device for monitoring breathing during sleep and control of CPAP treatment that is patient controlled
US5072737A (en) * 1989-04-12 1991-12-17 Puritan-Bennett Corporation Method and apparatus for metabolic monitoring
US5259373A (en) * 1989-05-19 1993-11-09 Puritan-Bennett Corporation Inspiratory airway pressure system controlled by the detection and analysis of patient airway sounds
US5632269A (en) 1989-09-22 1997-05-27 Respironics Inc. Breathing gas delivery method and apparatus
US5239995A (en) * 1989-09-22 1993-08-31 Respironics, Inc. Sleep apnea treatment apparatus
US5148802B1 (en) * 1989-09-22 1997-08-12 Respironics Inc Method and apparatus for maintaining airway patency to treat sleep apnea and other disorders
US5101820A (en) * 1989-11-02 1992-04-07 Christopher Kent L Apparatus for high continuous flow augmentation of ventilation and method therefor
US5392768A (en) * 1991-03-05 1995-02-28 Aradigm Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval
DE69430303T2 (en) * 1991-03-05 2002-11-28 Aradigm Corp A method and apparatus for correcting a zero signal of a pressure sensor for a flow meter
US5404871A (en) * 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
US5450336A (en) * 1991-03-05 1995-09-12 Aradigm Corporation Method for correcting the drift offset of a transducer
US5394866A (en) * 1991-03-05 1995-03-07 Aradigm Corporation Automatic aerosol medication delivery system and methods
US5458137A (en) * 1991-06-14 1995-10-17 Respironics, Inc. Method and apparatus for controlling sleep disorder breathing
DE69231157D1 (en) 1991-11-14 2000-07-13 Univ Technologies Int Automatic system for generating a continuous positive airway pressure
US5335654A (en) 1992-05-07 1994-08-09 New York University Method and apparatus for continuous adjustment of positive airway pressure for treating obstructive sleep apnea
US5803066A (en) * 1992-05-07 1998-09-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
US5490502A (en) 1992-05-07 1996-02-13 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
US5645054A (en) 1992-06-01 1997-07-08 Sleepnet Corp. Device and method for the treatment of sleep apnea syndrome
US5445054A (en) * 1993-09-21 1995-08-29 R. J. Reynolds Tobacco Company Sheet cutting apparatus and method
EP0927538B1 (en) 1993-11-05 2004-04-07 Rescare Limited Determination of airway patency
US6675797B1 (en) * 1993-11-05 2004-01-13 Resmed Limited Determination of patency of the airway
EP0656216B1 (en) * 1993-12-03 2000-07-05 Rescare Limited Estimation of flow and detection of breathing in CPAP treatment
US5456264A (en) 1994-03-31 1995-10-10 Universite Laval Accuracy of breath-by-breath analysis of flow volume loop in identifying flow-limited breathing cycles in patients
US5535738A (en) * 1994-06-03 1996-07-16 Respironics, Inc. Method and apparatus for providing proportional positive airway pressure to treat sleep disordered breathing
US5485851A (en) 1994-09-21 1996-01-23 Medtronic, Inc. Method and apparatus for arousal detection
US5551419A (en) * 1994-12-15 1996-09-03 Devilbiss Health Care, Inc. Control for CPAP apparatus
US5947115A (en) * 1995-01-26 1999-09-07 Respironics, Inc. Gas flow pressure filter
US5800361A (en) * 1995-02-06 1998-09-01 Ntc Technology Inc. Non-invasive estimation of arterial blood gases
DE69634261T2 (en) * 1995-10-23 2006-01-05 Resmed Ltd., North Ryde Air flow generator
US5826579A (en) 1995-11-01 1998-10-27 University Technologies International, Inc. Remote-controlled mandibular positioning device and method of using the device
US5944680A (en) * 1996-06-26 1999-08-31 Medtronic, Inc. Respiratory effort detection method and apparatus
DE69735557T2 (en) * 1996-09-23 2007-02-01 Resmed Ltd., North Ryde Device for determining the instantaneous elastic decrease pressure during ventilatory support
US6457472B1 (en) * 1996-12-12 2002-10-01 The Johns Hopkins University Method and apparatus for providing ventilatory support to a patient
DE19706092C2 (en) 1997-02-17 2000-02-24 Map Gmbh A method for switching into the inhalation or exhalation phase with a CPAP device
US6131571A (en) * 1997-04-30 2000-10-17 University Of Florida Ventilation apparatus and anesthesia delivery system
US6371114B1 (en) * 1998-07-24 2002-04-16 Minnesota Innovative Technologies & Instruments Corporation Control device for supplying supplemental respiratory oxygen
US5954050A (en) * 1997-10-20 1999-09-21 Christopher; Kent L. System for monitoring and treating sleep disorders using a transtracheal catheter
US6367474B1 (en) * 1997-11-07 2002-04-09 Resmed Limited Administration of CPAP treatment pressure in presence of APNEA
US6256508B1 (en) * 1998-02-27 2001-07-03 Mitsubishi Denki Kabushiki Kaisha Simultaneous broadcasting system, transmitter and receiver therefor
US6345619B1 (en) * 1998-05-25 2002-02-12 Resmed, Limited Control of the administration of continuous positive airway pressure treatment
US6213955B1 (en) * 1998-10-08 2001-04-10 Sleep Solutions, Inc. Apparatus and method for breath monitoring
EP1140263B1 (en) * 1999-01-15 2011-05-11 ResMed Limited Method and apparatus to counterbalance intrinsic positive end expiratory pressure
US6435182B1 (en) * 1999-03-24 2002-08-20 Trustees Of Boston University Enhanced ventilation waveform device
US6581599B1 (en) * 1999-11-24 2003-06-24 Sensormedics Corporation Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients
US6938619B1 (en) * 2000-06-13 2005-09-06 Scott Laboratories, Inc. Mask free delivery of oxygen and ventilatory monitoring
US6651658B1 (en) * 2000-08-03 2003-11-25 Sequal Technologies, Inc. Portable oxygen concentration system and method of using the same
US6666830B1 (en) * 2000-08-17 2003-12-23 East River Ventures, Lp System and method for detecting the onset of an obstructive sleep apnea event
US6814073B2 (en) * 2000-08-29 2004-11-09 Resmed Limited Respiratory apparatus with improved flow-flattening detection

Also Published As

Publication number Publication date Type
US8707953B2 (en) 2014-04-29 grant
US9782133B2 (en) 2017-10-10 grant
JP5099866B2 (en) 2012-12-19 grant
JP5466193B2 (en) 2014-04-09 grant
US7013893B2 (en) 2006-03-21 grant
US6814073B2 (en) 2004-11-09 grant
US20140200476A1 (en) 2014-07-17 application
JP2004506499A (en) 2004-03-04 application
US20020043264A1 (en) 2002-04-18 application
JP5822899B2 (en) 2015-11-25 grant
US20060112960A1 (en) 2006-06-01 application
JP2011143260A (en) 2011-07-28 application
EP1313526A4 (en) 2011-09-14 application
US7159588B2 (en) 2007-01-09 grant
US8739789B2 (en) 2014-06-03 grant
JP2014087662A (en) 2014-05-15 application
US20120304998A1 (en) 2012-12-06 application
WO2002018002A1 (en) 2002-03-07 application
US20050039750A1 (en) 2005-02-24 application
US20070084464A1 (en) 2007-04-19 application
EP1313526A1 (en) 2003-05-28 application

Similar Documents

Publication Publication Date Title
Bisgaard et al. Lung function measurement in awake young children
Hosselet et al. Detection of flow limitation with a nasal cannula/pressure transducer system
US6360741B2 (en) Pressure support system with a low leak alarm and method of using same
US5803066A (en) Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
US6609517B1 (en) Method and apparatus for providing positive airway pressure to a patient
US5307795A (en) Medical ventilators
US6068602A (en) Method and apparatus for determining airway resistance and lung compliance
US5503146A (en) Standby control for CPAP apparatus
US20080092894A1 (en) System and method for controlling respiratory therapy based on detected respiratory events
US6237592B1 (en) Auto-calibration of pressure transducer offset
US6705315B2 (en) Device for monitoring breathing during sleep and ramped control of CPAP treatment
US5490502A (en) Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
US5535738A (en) Method and apparatus for providing proportional positive airway pressure to treat sleep disordered breathing
Ayappa et al. Non-invasive detection of respiratory effort-related arousals (RERAs) by a nasal cannula/pressure transducer system
US5752921A (en) Method and apparatus for determining tracheal pressure
US7004908B2 (en) Method and apparatus useful in the diagnosis of obstructive sleep apnea of a patient
US20090007914A1 (en) Method and Apparatus for Resolving Upper Airway Obstruction, Resistance or Instability
US20070163590A1 (en) Methods and apparatus for the sytematic control of ventilatory support in the presence of respiratory insufficiency
US20080097234A1 (en) System and method for detecting respiratory events
US7270128B2 (en) Method and apparatus to counterbalance intrinsic positive end expiratory pressure
US7722546B2 (en) Method and device for carrying out a signal-processing viewing of a measurement signal that is correlated to the respiratory activity of an individual
US6709405B2 (en) Breathing apparatus and method for operation thereof for examining pulmonary mechanics of a respiratory system
US6752151B2 (en) Method and apparatus for providing variable positive airway pressure
US20060027234A1 (en) Autotitrating method and apparatus
EP0656216A2 (en) Estimation of flow and detection of breathing in CPAP treatment

Legal Events

Date Code Title Description
AS Assignment

Owner name: RESMED (R&D) LIMITED, AUSTRALIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WICKHAM, PETER JOHN DEACON;REEL/FRAME:045846/0004

Effective date: 20010809

AS Assignment

Owner name: RESMED LIMITED, AUSTRALIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RESMED (R&D) LIMITED;REEL/FRAME:045862/0307

Effective date: 20010809